Literature DB >> 559773

Adriamycin: effect on mammalian cardiac cells in culture. I. Cell population and energy metabolism.

M W Seraydarian, L Artaza, M F Goodman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 559773     DOI: 10.1016/s0022-2828(77)80004-7

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  6 in total

Review 1.  Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms.

Authors:  Jessica M Scott; Aarif Khakoo; John R Mackey; Mark J Haykowsky; Pamela S Douglas; Lee W Jones
Journal:  Circulation       Date:  2011-08-02       Impact factor: 29.690

2.  Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin.

Authors:  O Marcillat; Y Zhang; K J Davies
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

3.  The regulation of protein synthesis in heart muscle under normal conditions and in the adriamycin-cardiomyopathy.

Authors:  J Zähringer
Journal:  Klin Wochenschr       Date:  1981-12-01

4.  Reduced in vivo high-energy phosphates precede adriamycin-induced cardiac dysfunction.

Authors:  M Y Maslov; V P Chacko; G A Hirsch; A Akki; M K Leppo; C Steenbergen; R G Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-21       Impact factor: 4.733

5.  Detection of adriamycin-induced cardiotoxicity in cultured heart cells with technetium 99m-SESTAMIBI.

Authors:  D Piwnica-Worms; M L Chiu; J F Kronauge
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Creatine kinase-overexpression improves myocardial energetics, contractile dysfunction and survival in murine doxorubicin cardiotoxicity.

Authors:  Ashish Gupta; Cory Rohlfsen; Michelle K Leppo; Vadappuram P Chacko; Yibin Wang; Charles Steenbergen; Robert G Weiss
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.